Cargando…

Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study

Background. Extending the administration interval of erythropoiesis-stimulating agents (ESAs) represents an opportunity to improve the efficiency of anaemia management in patients with chronic kidney disease (CKD). However, effective haemoglobin (Hb) maintenance can be challenging with epoetin alfa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canaud, Bernard, Mingardi, Giulio, Braun, Johann, Aljama, Pedro, Kerr, Peter G., Locatelli, Francesco, Villa, Giuseppe, Van Vlem, Bruno, McMahon, Alan W., Kerloëguen, Cécile, Beyer, Ulrich
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Dialysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568005/ https://www.ncbi.nlm.nih.gov/pubmed/18586762 http://dx.doi.org/10.1093/ndt/gfn320

Ejemplares similares

Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study
por: Ethier, Jean, et al.
Publicado: (2008)

Extended dosing of darbepoetin alfa in peritoneal dialysis patients
por: Feriani, Mariano, et al.
Publicado: (2011)

Attitudes of nephrologists towards assisted home dialysis in Germany
por: Pommer, Wolfgang, et al.
Publicado: (2018)

Abdominal aortic calcification in dialysis patients: results of the CORD study
por: Honkanen, Eero, et al.
Publicado: (2008)

Repigmentation in vitiligo universalis after starting dialysis—could they be related?
por: Farahbakhsh, Navid, et al.
Publicado: (2018)

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting
por: Drechsler, Christiane, et al.
Publicado: (2009)

Clinical management of patients on peritoneal dialysis in Italy: results from the ATENA study
por: Crepaldi, Carlo, et al.
Publicado: (2018)

Intravenous drug users who require dialysis: causes of renal failure and outcomes
por: Scott, Jemima K, et al.
Publicado: (2018)

Comorbidity is not associated with dialysis modality choice in patients with end‐stage kidney disease
por: Bonenkamp, Anna A., et al.
Publicado: (2022)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status
por: Davies, Simon, et al.
Publicado: (2009)

Early changes in body weight and blood pressure are associated with mortality in incident dialysis patients
por: Duranton, Flore, et al.
Publicado: (2016)

Clinical course after parathyroidectomy in adults with end-stage renal disease on maintenance dialysis
por: Lim, Christopher Thiam Seong, et al.
Publicado: (2018)

Characterization of negative health outcomes for dialysis events by vascular access type—Tennessee, 2015–2019
por: Suhs, Tara, et al.
Publicado: (2023)

Outcomes of dialysis catheters placed by the Y-TEC peritoneoscopic technique: a single-center surgical experience
por: Al Azzi, Yorg, et al.
Publicado: (2016)

Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients
por: Milan Manani, Sabrina, et al.
Publicado: (2016)

Current apparent treatment‐resistant hypertension in patients undergoing peritoneal dialysis: A multi‐center cross‐sectional study
por: Li, Dan, et al.
Publicado: (2022)

Developing a statewide infection prevention program assessment service for dialysis settings using a six-sigma framework
por: Ludington, Chelsea, et al.
Publicado: (2023)

An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates
por: Holt, Stephen Geoffrey, et al.
Publicado: (2021)

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
por: Carrera, Fernando, et al.
Publicado: (2010)

Causes and risk factors for acute dialysis initiation among patients with end-stage kidney disease—a large retrospective observational cohort study
por: Arulkumaran, Nish, et al.
Publicado: (2018)

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study
por: Vychytil, Andreas, et al.
Publicado: (2008)

A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea‐190H) to a standard high flux polysulfone dialyser membrane (FX‐80) in the setting of extended hours haemodialysis
por: Kameshwar, Kamya, et al.
Publicado: (2022)

Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial
por: Forni, Valentina, et al.
Publicado: (2013)

Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
por: Ma, Terry King-Wing, et al.
Publicado: (2016)

C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
por: Roger, Simon D., et al.
Publicado: (2011)

Using manual exchanges for an urgent-start peritoneal dialysis program
por: Naljayan, Mihran V, et al.
Publicado: (2018)

Peritoneal dialysis catheter leakage following intermittent vacuum therapy
por: Leenen, Esther, et al.
Publicado: (2018)

The modality of choice, manual or automated, for urgent start peritoneal dialysis
por: Javaid, Muhammad M, et al.
Publicado: (2019)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation
por: Auricchio, Sara, et al.
Publicado: (2018)

Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients
por: Tepel, Martin, et al.
Publicado: (2008)

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
por: Hutchison, Alastair J., et al.
Publicado: (2008)

Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth
por: Taniguchi, Masatomo, et al.
Publicado: (2008)

Japanese haemodialysis anaemia management practices and outcomes (1999–2006): results from the DOPPS
por: Akizawa, Tadao, et al.
Publicado: (2008)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids
por: Gabutti, Luca, et al.
Publicado: (2009)

Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
por: Rodríguez-García, Minerva, et al.
Publicado: (2009)

Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)
por: Steczko, Janusz, et al.
Publicado: (2009)

The mortality risk of overhydration in haemodialysis patients
por: Wizemann, Volker, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r5c98dumi0hnmus8coihs32q3i